Prostate Cancer 3+3, or Prostate Cancer Gleason Score 3+3, is an option for some patients to opt out of surgery and be treated with watchful waiting or other modalities.
For patients with prostate cancer Gleason score 3+3, the two 3s represent the primary and secondary tissue areas of prostate cancer tissue. For low-risk prostate cancer, those with a life expectancy of more than 10 years, or those who are fully informed and active in their choices and can actively cooperate with monitoring and follow-up, they can choose not to have surgery.
In addition to the surgical approach, there are also radical radiation therapy, neoadjuvant hormone therapy, endocrine therapy and other treatment options. Patients with prostate cancer 3+3 are advised to go to regular hospitals, consult with a professional doctor, and deal with it actively.